Tumor-derived granulocyte colony-stimulating factor (G-CSF) results in the elevation of neutrophil levels that release neutrophil extracellular traps (NETs), which increases the risk of VTE in patients with lung cancer (12). Here, CSF3 is linked to lung carcinoma.